Fatal pancytopenia and methotrexate-trimethoprim-sulfamethoxazole interaction

Harefuah

Volumn 143, Issue 6, 2004, Pages

  Bartha, Peter ^a   Bron, Rita ^a   Levy, Yishai ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Folate; Methotrexate; Pancytopenia; Rheumatoid arthritis; Trimethoprim Sultamethoxazole

Indexed keywords

COTRIMOXAZOLE; METHOTREXATE;

ARTICLE; BACTERIAL INFECTION; CANDIDA ALBICANS; CASE REPORT; DOSE RESPONSE; FATALITY; HIGH RISK PATIENT; HUMAN; INFLAMMATION; PANCYTOPENIA; RHEUMATOID ARTHRITIS; SIDE EFFECT;

AGED; DIAGNOSIS, DIFFERENTIAL; DRUG INTERACTIONS; FATAL OUTCOME; FEMALE; HUMANS; METHOTREXATE; PANCYTOPENIA; SULFAMETHOXAZOLE;

EID: 19244365835     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Govert JA, Patton S & Fine RL, Pancytopenia from using trimethoprim and methotrexate. Letter. An'n Intern Med, 1998; 117: 877-878.
2. Barnhart K, Coutifaris C & Esposito M, The pharmacology of methotrexate. Expert Opin Pharmacother, 2001; 2: 409-417.
3. Genestier L, Paillot R, Quemeneur L & al, Mechanism of activity of methotrexate. Immunopharmacology, 2000; 47: 247-257.
4. Getov I, Dimitrova Z & Petkova V, Low dose treatment with methotrexate - adverse drug reactions survey. Boll Chim Farm, 2000; 139: 153-158.
5. Schroeder F & Schroeder JO, Methotrexate Dtsch Med Wochenschr, 2000; 125: 1435-1436.
6. Held-Warmkessel J, Methotrexate. Clin J Oncol Nurs, 2000; 4: 187-188.
7. Kalke S, Balakrishnan C, Mittal G & al, Complications with low dose methotrexate in rheumatoid arthritis. J Assoc Physicians India, 1997; 45: 903-904.
8. Jones KW & Patel SR, A family physician's guide to monitoring methotrexate. Am Fam Physician, 2000; 62: 1607-1612.
9. Rodriguez-Gomez M, Fernandez-Suiero JL, Ulibarrena C & al, Severe myelotoxicity in rheumatoid arthritis patients treated with oral methotrexate. Clin Exp Rheumatol, 2001; 19: 353.
10. Dan M & Shapira I, Possible role of methotrexate in trimethoprim-sulphamethoxazole induced acute megaloblastic anemia. Isr J Med Sci, 1984; 20: 262-263.
11. Thomas MH & Gutterman LA, Methotrexate toxicity in a patient receiving trimethoprim-sulfamethoxazole. J Reumatol, 1986; 13: 440-441.
12. Frain JB, Methotrexate toxicity in a patient receiving trimethoprim-sulfamethoxazole. J Rheumatol, 1987; 14: 176-177.
13. Thevenet JP, Ristori JM, Cure H & al, Pancytopenia during treatment of rheumatoid arthritis with methotrexate after administration of trimethoprim-sulfamethoxazole. Presse Med, 1987; 16: 1487.
14. Thomas DR, Dover JS & Camp RD, Pancytopenia induced by interaction between methotrexate and trimethoprim-sulphamethoxazole. J Am Acad Dermatol, 1987; 17: 1055-1056.
15. Liddle BJ & Marsden JR, Drug interactions with methotrexate. Br J Dermatol, 1989; 120: 582-583.
16. Carmichael AJ, Pneumocystis carinii pneumonia following methotrexate. Br J Dermatol, 1990; 122: 291.
17. Groenendal H & Rampen FH, Methotrexate and trimethoprim- sulphametoxazole - a potentially hazardous combination. Clin Exp Dermatol, 1990; 15: 358-360.
18. Chevrel G, Brantus JF, Sainte-Laudy J & Miossec P, Allergic pancytopenia to trimethoprim-sulphametoxazole for Pneumocystic carinii pneumonia following methotrexate treatment for rheumatoid arthritis. Letter. Rheumatology, 1999; 38: 475-476.
19. Nanke Y, Kotake S, Akama H & al, Pancytopenia and colitis with Clostridium difficile in a rheumatoid arthritis patient taking methotrexate, antibiotics and non-steroidal antiinfammatory drugs. Clin Rheumatol, 2001; 20: 73-75.
20. Shilsky RL, Antimetabolites. In: Perry MC (Ed). The Chemotherapy Sourcebook. Williams & Wilkins, Baltimore, MD, 1992; pp 301-317.
21. Cermanova J, Chladek J, Sispera L & Martinkova J, Renal excretion of methotrexate in an in vivo model in minipigs. Acta Medica (Hradec Kralove), 2000; 43(Suppl): 139-147.
22. Furst DE, Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis. Br J Rheumatol, 1995; 34 (Suppl 2): 20-25.
23. Ferrazzini G, Klein J, Sulh H & al, Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukaemia. J Pediatr, 1990; 117: 823-826.
24. Hande K, Gober J & Fletcher R, Trimethoprim Interfers with serum methotrexate assay by the competitive protein binding technique. Clin Chem, 1980; 26: 1617-1619.
25. van Ede AE, Laan RF, Rood MJ & al, Effect of folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo controlled study. Arthritis Rheum, 2001; 44: 1515-1524.
26. Endresen GK & Husby G, Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines. Scand J Rheumatol, 2001; 30: 129-134.